SCHEMBL17797802

SCHEMBL17797802

CCCCOCCOCCc1c(C(=O)O)ccc(C(=O)O)c1CCOCCOCCCC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 7/20 0.53
RARA P10276 3/20 0.53
RARG P13631 2/20 0.44
PPARA Q07869 2/20 0.42
PPARG P37231 1/20 0.42
GABRP O00591 1/20 0.42
GABRD O14764 1/20 0.42
GABRA1 P14867 1/20 0.42
GABRB1 P18505 1/20 0.42
GABRG2 P18507 1/20 0.42
GABRB3 P28472 1/20 0.42
GABRA5 P31644 1/20 0.42
GABRA3 P34903 1/20 0.42
GABRA2 P47869 1/20 0.42
GABRB2 P47870 1/20 0.42
GABRA4 P48169 1/20 0.42
GABRE P78334 1/20 0.42
GABRA6 Q16445 1/20 0.42
GABRG1 Q8N1C3 1/20 0.42
GABRG3 Q99928 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17797799 0.98 RARB (0.51) RARBRARARARGPPARAPPARG
SCHEMBL29396469 0.95 RARB (0.49) RARBRARARARGPPARAPPARG
SCHEMBL9840142 0.88 RARB (0.44) RARBRARARARGTSHRTP53
SCHEMBL3677297 0.87 RARB (0.46) RARBRARARARGPPARAPPARG
SCHEMBL17797914 0.86 ALDH1A1 (0.42) RARBRARARARGPPARAPPARG
SCHEMBL17797929 0.85 RARB (0.44) RARBRARARARGPPARAPPARG
SCHEMBL658635 0.84 RARB (0.46) RARBRARARARGPPARAPPARG
SCHEMBL1498029 0.83 TSHR (0.44) RARBRARARARGPPARAPPARG
SCHEMBL17797832 0.82 CYP1A2 (0.43) RARBRARAPPARAPPARGGABRP
SCHEMBL107819 0.82 RARB (0.44) RARBRARARARGPPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11358376-B2 Poly(vinyl acetal) resin compositions, layers, and interlayers having enhanced optical properties SOLUTIA INC. (US) 2022-06-14 US claimed
US-20190202179-A1 POLY(VINYL ACETAL) RESIN COMPOSITIONS, LAYERS, AND INTERLAYERS HAVING ENHANCED OPTICAL PROPERTIES SOLUTIA INC. (US) 2019-07-04 US claimed
US-20160159051-A1 POLY(VINYL ACETAL) RESIN COMPOSITIONS, LAYERS, AND INTERLAYERS HAVING ENHANCED OPTICAL PROPERTIES SOLUTIA INC. (US) 2016-06-09 US claimed
US-20260146138-A1 METHODS OF RECYCLING POLYVINYL BUTYRAL SOLUTIA INC. (US) 2026-05-28 US disclosed
WO-2025216962-A1 MULTIPLE STAGE PYROLYSIS OF RECYCLED PVB OF VARYING COMPOSITIONS EASTMAN CHEMICAL COMPANY (US) 2025-10-16 WO disclosed
WO-2025216961-A1 RECYCLING OF GLASS-CONTAINING PVB WASTES VIA HIGH TEMPERATURE TREATMENT EASTMAN CHEMICAL COMPANY (US) 2025-10-16 WO disclosed
WO-2025216960-A1 MULTIPLE STAGE PYROLYSIS OF RECYCLED PVB OF VARYING COMPOSITIONS EASTMAN CHEMICAL COMPANY (US) 2025-10-16 WO disclosed
WO-2024076944-A1 METHODS OF RECYCLING POLYVINYL BUTYRAL SOLUTIA INC. (US) 2024-04-11 WO disclosed
US-9809006-B2 Polymer interlayers having improved sound insulation properties SOLUTIA INC. (US) 2017-11-07 US disclosed
US-20160159051-A1 POLY(VINYL ACETAL) RESIN COMPOSITIONS, LAYERS, AND INTERLAYERS HAVING ENHANCED OPTICAL PROPERTIES SOLUTIA INC. (US) 2016-06-09 US disclosed
US-20160159039-A1 POLYMER INTERLAYERS HAVING IMPROVED SOUND INSULATION PROPERTIES SOLUTIA INC. (US) 2016-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260146138-A1 METHODS OF RECYCLING POLYVINYL BUTYRAL AGL, VMP1, FTO RARB 457/4885RARA 980/4885RARG 721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.